rs112772376
×
Entrez Id:
286053
Gene Symbol:
NSMCE2
NSMCE2
RDW - Red blood cell distribution width result
0.700
GeneticVariation
GWASCAT
Leveraging Polygenic Functional Enrichment to Improve GWAS Power.
30595370
2019
rs112772376
×
Entrez Id:
286053
Gene Symbol:
NSMCE2
NSMCE2
Red cell distribution width determination
0.700
GeneticVariation
GWASCAT
Leveraging Polygenic Functional Enrichment to Improve GWAS Power.
30595370
2019
rs11778726
×
Entrez Id:
286053
Gene Symbol:
NSMCE2
NSMCE2
White Blood Cell Count procedure
0.700
GeneticVariation
GWASCAT
Leveraging Polygenic Functional Enrichment to Improve GWAS Power.
30595370
2019
rs16900452
×
Entrez Id:
286053
Gene Symbol:
NSMCE2
NSMCE2
Eosinophil count procedure
0.700
GeneticVariation
GWASCAT
Leveraging Polygenic Functional Enrichment to Improve GWAS Power.
30595370
2019
rs4466418
×
Entrez Id:
286053
Gene Symbol:
NSMCE2
NSMCE2
Oral Ulcer
A
0.700
GeneticVariation
GWASCAT
Genome wide analysis for mouth ulcers identifies associations at immune regulatory loci.
30837455
2019
rs2891677
×
Entrez Id:
286053
Gene Symbol:
NSMCE2
NSMCE2
C-reactive protein measurement
C
0.700
GeneticVariation
GWASCAT
Genome Analyses of >200,000 Individuals Identify 58 Loci for Chronic Inflammation and Highlight Pathways that Link Inflammation and Complex Disorders.
30388399
2018
rs201447509
×
Entrez Id:
286053
Gene Symbol:
NSMCE2
NSMCE2
Schizophrenia
ATC
0.700
GeneticVariation
GWASCAT
Genome-wide association study of paliperidone efficacy.
27846195
2017
rs757613817
×
Entrez Id:
286053
Gene Symbol:
NSMCE2
NSMCE2
SECKEL SYNDROME 10
A
0.700
CausalMutation
CLINVAR
rs773917653
×
Entrez Id:
286053
Gene Symbol:
NSMCE2
NSMCE2
SECKEL SYNDROME 10
AAGGG
0.700
CausalMutation
CLINVAR
rs7008482
×
Entrez Id:
286053
Gene Symbol:
NSMCE2
NSMCE2
Malignant neoplasm of prostate
0.020
GeneticVariation
BEFREE
SNPs rs6983561, rs7008482 , and rs16901979 were significantly associated with CaP risk in WAs (P < 0.03).
22234922
2012
rs7008482
×
Entrez Id:
286053
Gene Symbol:
NSMCE2
NSMCE2
Prostate carcinoma
0.020
GeneticVariation
BEFREE
SNPs rs6983561, rs7008482 , and rs16901979 were significantly associated with CaP risk in WAs (P < 0.03).
22234922
2012
rs7008482
×
Entrez Id:
286053
Gene Symbol:
NSMCE2
NSMCE2
Malignant neoplasm of prostate
0.020
GeneticVariation
BEFREE
We report that rs7008482 , which maps to the 8q24.13 region, is an additional independent prostate cancer risk variant (P = 5 x 10(-4)), and we also replicate the association of rs16901979 with prostate cancer (P = 0.002).
17978284
2007
rs7008482
×
Entrez Id:
286053
Gene Symbol:
NSMCE2
NSMCE2
Prostate carcinoma
0.020
GeneticVariation
BEFREE
We report that rs7008482 , which maps to the 8q24.13 region, is an additional independent prostate cancer risk variant (P = 5 x 10(-4)), and we also replicate the association of rs16901979 with prostate cancer (P = 0.002).
17978284
2007
rs7008482
×
Entrez Id:
286053
Gene Symbol:
NSMCE2
NSMCE2
Primary malignant neoplasm
0.010
GeneticVariation
BEFREE
There was little indication that 8q24 SNPs associated with other cancer types--rs7008482 , rs7000448, rs6983561, rs6983267, rs13281615, rs13254738, or rs10090154--are associated with bladder cancer risk.
21051319
2010
rs7008482
×
Entrez Id:
286053
Gene Symbol:
NSMCE2
NSMCE2
Malignant Neoplasms
0.010
GeneticVariation
BEFREE
There was little indication that 8q24 SNPs associated with other cancer types--rs7008482 , rs7000448, rs6983561, rs6983267, rs13281615, rs13254738, or rs10090154--are associated with bladder cancer risk.
21051319
2010
rs7008482
×
Entrez Id:
286053
Gene Symbol:
NSMCE2
NSMCE2
Colorectal Carcinoma
0.010
GeneticVariation
BEFREE
We found rs7008482 in 8q24 region 4 to be significantly associated with CRC in European Americans (P = 0.03).
19520795
2009